We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA faces a significant number of security vulnerabilities that threaten the confidentiality and integrity of its industry and public health data, a congressional watchdog said. Read More
Lawmakers have called on the Department of Justice to investigate whether Mylan violated the law by misclassifying its severe allergy treatment EpiPen as a generic in the Medicaid Drug Rebate Program. Read More
Alcon Pharmaceuticals is asking the FDA to apply stricter requirements on bioequivalence studies intended to supplement applications for Durezol and Ciprodex generics. Read More
A group of pharmaceutical companies has filed a joint amicus brief defending ex-Acclarent executives William Facteau and Patrick Fabian, urging a federal court to acquit them of misdemeanor charges. Read More